Can antipsychotic use protect from COVID-19?
作者信息
Dratcu Luiz, Boland Xavier
机构信息
Maudsley Hospital, South London and Maudsley NHS Foundation Trust, Denmark Hill, London SE5 8AZ, United Kingdom.
出版信息
Schizophr Res. 2021 Oct;236:1-2. doi: 10.1016/j.schres.2021.07.035. Epub 2021 Jul 30.
Abstract
摘要
相似文献
1
Can antipsychotic use protect from COVID-19?
Schizophr Res. 2021 Oct;236:1-2. doi: 10.1016/j.schres.2021.07.035. Epub 2021 Jul 30.
2
Long acting injectable antipsychotics: Uninterrupted use during the COVID-19 pandemic.
J Psychiatr Ment Health Nurs. 2022 Feb;29(1):169-170. doi: 10.1111/jpm.12750. Epub 2021 Mar 10.
3
Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19.
Gen Hosp Psychiatry. 2021 Jul-Aug;71:137-139. doi: 10.1016/j.genhosppsych.2021.05.005. Epub 2021 May 23.
4
An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.
Schizophr Res. 2021 Jul;233:99-100. doi: 10.1016/j.schres.2021.06.019. Epub 2021 Jun 23.
5
Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
Schizophr Res. 2022 Mar;241:140-141. doi: 10.1016/j.schres.2022.01.035. Epub 2022 Jan 24.
6
The role of antipsychotics against COVID-19: A topic for debate.
Schizophr Res. 2021 Sep;235:5-6. doi: 10.1016/j.schres.2021.07.003. Epub 2021 Jul 8.
7
An overall protective effect of antipsychotic drugs against COVID-19 seems implausible.
Schizophr Res. 2022 May;243:486-488. doi: 10.1016/j.schres.2021.12.020. Epub 2021 Dec 22.
8
Antipsychotics, COVID-19, and Secondary Healthcare Databases: Revisiting the Pandemic.
Int J Neuropsychopharmacol. 2024 Jul 1;27(7). doi: 10.1093/ijnp/pyae026.
9
From predictions to evidence: Treatment compliance, disease progression and social compliance of patients with schizophrenia in the COVID-19 pandemic.
Perspect Psychiatr Care. 2021 Oct;57(4):1991-1998. doi: 10.1111/ppc.12824. Epub 2021 May 3.
10
Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic.
Health Aff (Millwood). 2021 Jun;40(6):904-909. doi: 10.1377/hlthaff.2021.00028.
引用本文的文献
1
Adherence to Antipsychotics, COVID-19 and Stigma: A Rainbow After the Storm?
Actas Esp Psiquiatr. 2025 May;53(3):616-620. doi: 10.62641/aep.v53i3.1813.
2
Antipsychotics, COVID-19, and Secondary Healthcare Databases: Revisiting the Pandemic.
Int J Neuropsychopharmacol. 2024 Jul 1;27(7). doi: 10.1093/ijnp/pyae026.
3
DRaW: prediction of COVID-19 antivirals by deep learning-an objection on using matrix factorization.
BMC Bioinformatics. 2023 Feb 15;24(1):52. doi: 10.1186/s12859-023-05181-8.
4
Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study.
Schizophr Res. 2023 Apr;254:1-7. doi: 10.1016/j.schres.2023.01.020. Epub 2023 Jan 20.
5
COVID-19 outbreak in a psychiatric hospital: what makes it worse?
Ann Gen Psychiatry. 2022 Jul 11;21(1):26. doi: 10.1186/s12991-022-00403-4.
6
Clozapine and COVID-19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study.
Acta Psychiatr Scand. 2022 Aug;146(2):168-178. doi: 10.1111/acps.13428. Epub 2022 Apr 1.
7
Antipsychotics and COVID-19: the debate goes on.
Lancet Psychiatry. 2021 Dec;8(12):1030. doi: 10.1016/S2215-0366(21)00396-5.
本文引用的文献
1
Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis.
Front Pharmacol. 2021 Mar 2;12:646701. doi: 10.3389/fphar.2021.646701. eCollection 2021.
2
Antipsychotic use and psychiatric disorders in COVID-19.
Lancet Healthy Longev. 2021 Feb;2(2):e64. doi: 10.1016/S2666-7568(20)30063-5. Epub 2021 Feb 3.
3
Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population.
Schizophr Res. 2021 Mar;229:53-54. doi: 10.1016/j.schres.2021.02.002. Epub 2021 Feb 19.
4
Serum interleukin-6 in schizophrenia: A system review and meta-analysis.
Cytokine. 2021 May;141:155441. doi: 10.1016/j.cyto.2021.155441. Epub 2021 Jan 30.
5
Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis.
Lancet Healthy Longev. 2020 Nov;1(2):e69-e79. doi: 10.1016/S2666-7568(20)30013-1. Epub 2020 Oct 26.
6
Does Nicotine Prevent Cytokine Storms in COVID-19?
Cureus. 2020 Oct 28;12(10):e11220. doi: 10.7759/cureus.11220.
7
Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.
Lancet Psychiatry. 2020 Dec;7(12):1025-1031. doi: 10.1016/S2215-0366(20)30421-1. Epub 2020 Sep 17.
8
Clozapine in the Time of COVID-19.
Clin Psychopharmacol Neurosci. 2020 Aug 31;18(3):450-453. doi: 10.9758/cpn.2020.18.3.450.
9
COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
10
Repositioning of the antipsychotic drug TFP for sepsis treatment.
J Mol Med (Berl). 2019 May;97(5):647-658. doi: 10.1007/s00109-019-01762-4. Epub 2019 Mar 8.
Zotero 插件